ABSTRACT
Background The epidemic outbreak cased by coronavirus 2019-nCoV is of great interest to researches because of the high rate of spread of the infection and the significant number of fatalities. A detailed scientific analysis of the phenomenon is yet to come, but the public is already interested in the questions of the duration of the epidemic, the expected number of patients and deaths. For long time predictions, the complicated mathematical models are necessary which need many efforts for unknown parameters identification and calculations. In this article, some preliminary estimates will be presented.
Objective Since the reliable long time data are available only for mainland China, we will try to predict the epidemic characteristics only in this area. We will estimate some of the epidemic characteristics and present the most reliable dependences for victim numbers, infected and removed persons versus time.
Methods In this study we use the known SIR model for the dynamics of an epidemic, the known exact solution of the linear equations and statistical approach developed before for investigation of the children disease, which occurred in Chernivtsi (Ukraine) in 1988-1989.
Results The optimal values of the SIR model parameters were identified with the use of statistical approach. The numbers of infected, susceptible and removed persons versus time were predicted.
Conclusions Simple mathematical model was used to predict the characteristics of the epidemic caused by coronavirus 2019-nCoV in mainland China. The further research should focus on updating the predictions with the use of fresh data and using more complicated mathematical models.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
I would like to express my sincere thanks to professors Dirk Langemann (Techniche Universitaet Braunschweig) and Juergen Prestin (Universitaet zu Luebeck) for their support in developing the used optimization approach. I would like to thank also professors Alberto Redaelli, Giuseppe Passoni and Gianfranco Fiore (Politecnico di Milano), S. Pereverzyev (RICAM, Linz, Ausria) for involving me in very interesting biomedical investigations in frames of EU-financed Horizon-2020 projects EUMLS (Grant agreement PIRSES-GA-2011-295164-EUMLS) and AMMODIT (Grant Number MSCA-RISE 645672).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
inesteruk{at}yahoo.com
Data Availability
The data used are available in the text
